General Information of Drug (ID: DM2LFZD)

Drug Name
iPSC-derived RPE (autologous)
Indication
Disease Entry ICD 11 Status REF
Wet age-related macular degeneration 9B78.3Z Phase 1 [1]
Drug Type
Human embryonic stem (hES) cell-derived therapeutics
Cross-matching ID
TTD ID
D04MBQ

References

1 Japan stem-cell trial stirs envy. Nature. 2014 Sep 18;513(7518):287-8.